RAJKUMAR VENKATRAMANI to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications RAJKUMAR VENKATRAMANI has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.432
-
Event-free survival in relapsed and refractory rhabdomyosarcoma treated on cooperative group phase II trials: A report from the Children's Oncology Group. Pediatr Blood Cancer. 2024 Jul; 71(7):e31009.
Score: 0.217
-
Outcome of patients with relapsed or refractory nonrhabdomyosarcoma soft tissue sarcomas enrolled in phase 2 cooperative group clinical trials: A report from the Children's Oncology Group. Cancer. 2024 Jul 15; 130(14):2493-2502.
Score: 0.215